Sandbox:Balanitis

Revision as of 18:56, 16 January 2017 by Vishal (talk | contribs)
Jump to navigation Jump to search


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vishal Devarkonda, M.B.B.S[2]

Synonyms and keywords: balanoposthitis

Overview

Historical Perspective

Classification

Pathophysiology

Infectious

Non-infectious

Causes

Causes of Balanitis include the following:

  1. Candidal balanitis
  2. Anaerobic balanitis
  3. Aerobic balanitis
  4. Lichen sclerosus
  5. Lichen planus
  6. Zoon’s (plasma cell) balanitis
  7. Psoriasis and circinate balanitis
  8. Eczema (including irritant, allergic and seborrhoeic)
  9. Non-specific balanoposthitis
  10. Fixed drug eruptions

Premalignant conditions:

  1. Erythroplasia of Queyrat
  2. Bowen’s disease
  3. Bowenoid papulosis

Miscellaneous

Stevens-Johnson syndrome

Differentiating Candida Vulvovaginitis from other Diseases

Candida Vulvovaginitis must be differentiated from the following diseases which have a similar presentation:[1][2][3][4][5]

Disease Findings
Trichomoniasis
  • Presents with purulent, malodorous, thin discharge associated with burning, pruritus, and dysuria, with the signs of vaginal inflammation and elevated vaginal pH (>4.5)
  • Motile trichomonads on wet mount are demonstrated
  • Positive culture (Gold standard)
  • Positive nucleic acid amplification test (NAAT)
Atrophic vaginitis
  • Progressive symptoms
  • Presents with yellow and malodorous vaginal discharge, vaginal dryness, postcoital bleeding, and dyspareunia with the signs of vaginal inflammation and elevated vaginal pH (>5)
  • Diagnosis is critical and laboratory tests help to confirm hypoestrogenic state
Desquamative inflammatory vaginitis
  • Chronic clinical syndrome with unknown etiology
  • Presents with dyspareunia, dyspareunia, yellow, grey, or green profuse vaginal discharge with the signs of vaginal inflammation and elevated vaginal pH (>4.5)
  • Microscopy shows large number of parabasal (immature squamous epithelial cells) and inflammatory cells
Bacterial Vaginosis
  • Presents with dysuria, vaginal discharge
  • Fishy odor (positive whiff test)
  • Normal vaginal PH (<4.5)
  • On speculum examination signs of vaginal inflammation are demonstrated.

Epidemiology and Demographics

  • Epidemiological studies on Candida vulvovaginitis are hard to perform, because of several factors:[6][7]
    • Candida vulvovaginitis is not a reportable disease.
    • The diagnosis of Candida vulvovaginitis is based on clinical presentation and positive laboratory findings. Relying on a positive culture alone would likely overestimate the prevalence of Candida vulvovaginitis.
    • The use of over-the-counter (OTC) topical anti-fungals makes it difficult to conduct epidemiological studies.
  • Candida is the second most common cause of vaginal infection in young women following Bacterial Vaginosis.[8]

Age

  • Incidence of Candida vulvovaginitis is higher in pregnant women.[9][10]
  • Women in reproductive age group are prone for Candida vulvovaginits and at least one episode is reported in 70 to 75% in this population group.[11]
  • 40 to 50% of patients with a prior yeast infection have multiple episodes of yeast infection.[9]
  • Among the adult population 5 to 8% women have more than four episodes of infection.[12]
  • In 20% asymptomatic healthy adolescent women, candida species can be isolated from the vagina.[13]

Race

Candida vulvovaginitis is more prevalent among African American women than white American women.[12]

Risk Factors

Risk factors for Balanitis include:

  • Uncircumcised penis
  • Antibiotic use
  • Corticosteroid use
  • Immunocompromised
  • Diabetes
  • Not usually considered sexually transmitted

Screening

There are no screening procedures for Balanitis.

Natural History, Complications and Prognosis

Natural History

Prognosis

Complications

Diagnosis

History and Symptoms

Symptoms include:

  • Redness of foreskin or penis
  • Other rashes on the head of the penis
  • Foul-smelling discharge
  • Painful penis and foreskin

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Surgical Therapy

Prevention

Primary Prevention

Secondary Prevention

References

  1. Centers for Disease Control and Prevention. 2015 Sexually Transmitted Diseases Treatment Guidelines. Bacterial Vaginosis. http://www.cdc.gov/std/tg2015/bv.htm Accessed on October 13, 2016
  2. Bachmann GA, Nevadunsky NS (2000). "Diagnosis and treatment of atrophic vaginitis". Am Fam Physician. 61 (10): 3090–6. PMID 10839558.
  3. Krieger JN, Tam MR, Stevens CE, Nielsen IO, Hale J, Kiviat NB; et al. (1988). "Diagnosis of trichomoniasis. Comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens". JAMA. 259 (8): 1223–7. PMID 2448502.
  4. Sobel JD, Reichman O, Misra D, Yoo W (2011). "Prognosis and treatment of desquamative inflammatory vaginitis". Obstet Gynecol. 117 (4): 850–5. doi:10.1097/AOG.0b013e3182117c9e. PMID 21422855.
  5. Eckert LO, Hawes SE, Stevens CE, Koutsky LA, Eschenbach DA, Holmes KK (1998). "Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm". Obstet Gynecol. 92 (5): 757–65. PMID 9794664.
  6. Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, Reed BD, Summers PR (1998). "Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations". Am. J. Obstet. Gynecol. 178 (2): 203–11. PMID 9500475.
  7. Sobel JD (2007). "Vulvovaginal candidosis". Lancet. 369 (9577): 1961–71. doi:10.1016/S0140-6736(07)60917-9. PMID 17560449.
  8. Allsworth JE, Peipert JF (2007). "Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data". Obstet Gynecol. 109 (1): 114–20. doi:10.1097/01.AOG.0000247627.84791.91. PMID 17197596.
  9. 9.0 9.1 Hurley R, De Louvois J (1979). "Candida vaginitis". Postgrad Med J. 55 (647): 645–7. PMC 2425644. PMID 523355.
  10. García Heredia M, García SD, Copolillo EF, Cora Eliseth M, Barata AD, Vay CA; et al. (2006). "[Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents]". Rev Argent Microbiol. 38 (1): 9–12. PMID 16784126.
  11. Zuckerman, Andrea; Romano, Mary (2016). "Clinical Recommendation: Vulvovaginitis". Journal of Pediatric and AdolescentGynecology. 29 (6): 673–679. doi:10.1016/j.jpag.2016.08.002. ISSN 1083-3188.
  12. 12.0 12.1 Foxman B, Marsh JV, Gillespie B, Sobel JD (1998). "Frequency and response to vaginal symptoms among white and African American women: results of a random digit dialing survey". J Womens Health. 7 (9): 1167–74. PMID 9861594.
  13. Barousse, M M (2004). "Vaginal yeast colonisation, prevalence of vaginitis, and associated local immunity in adolescents". Sexually Transmitted Infections. 80 (1): 48–53. doi:10.1136/sti.2002.003855. ISSN 1368-4973.